Full Text
PRS69 - IMPACT OF THE INTERNATIONAL REFERENCE PRICING ON ACCESS TO STANDARD THERAPY DRUGS FOR COPD

Abstract

Authors

M. Višňanský A. Butalova

Back to Volume 21, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×